PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

Source:http://linkedlifedata.com/resource/pubmed/id/17693134

Download in:

View as

General Info

PMID
17693134